In the present study, we elucidated the mechanism(s) by which inhibition of the Src and the MAPK pathways exert anti-tumor effects, specifically through growth and apoptosis, and identified therapeutic strategies to enhance this effect. The gene discussed is SRC; the disease is neoplasm.